Prospect Capital Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eton Pharmaceutcials
ETON
|
+$4.61M |
| 2 |
InterDigital
IDCC
|
+$4.54M |
| 3 |
Prenetics Global
PRE
|
+$4.36M |
| 4 |
Fennec Pharmaceuticals
FENC
|
+$4.06M |
| 5 |
OSI Systems
OSIS
|
+$2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Silicon Motion
SIMO
|
+$10.6M |
| 2 |
Dave Inc
DAVE
|
+$7.45M |
| 3 |
Celsius Holdings
CELH
|
+$4.63M |
| 4 |
InMode
INMD
|
+$4.29M |
| 5 |
TTM Technologies
TTMI
|
+$2.07M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.3% |
| 2 | Financials | 15.32% |
| 3 | Consumer Discretionary | 13.89% |
| 4 | Industrials | 13.23% |
| 5 | Consumer Staples | 11.48% |
Similar funds
Prospect Capital Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, Prospect Capital Advisors held 32 positions worth $220M, up 22% from $180M the previous quarter. Its ten largest holdings account for 58% of the portfolio.
Prospect Capital Advisors withdrew a net $9.19M in Q2 2026, closing 2 positions and reducing 9 holdings. Its most notable exit was Celsius Holdings, an estimated $4.63M position sold in full.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 34% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Prospect Capital Advisors opened a new position in Eton Pharmaceutcials worth $5.69M.
- Prospect Capital Advisors's largest Q2 2026 buy was Eton Pharmaceutcials: 157,200 shares worth $5.69M.
- Prospect Capital Advisors added most to InterDigital in Q2 2026, an estimated $4.54M increase.
- Prospect Capital Advisors's biggest Q2 2026 reduction was Silicon Motion, cutting an estimated $10.6M.
- Prospect Capital Advisors fully exited Celsius Holdings in Q2 2026, selling an estimated $4.63M.
- Prospect Capital Advisors's ten largest holdings make up 58% of its $220M portfolio in Q2 2026.
- Prospect Capital Advisors opened 4 new positions and closed 2 in Q2 2026.
- Prospect Capital Advisors's portfolio value rose 22% quarter-over-quarter to $220M.
Based on Prospect Capital Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.